Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2019-04-04
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevent Non-communicable Diseases Through Screening and Educating Emergency Department Attendees to Adopt Healthy Lifestyles
NCT06889792
Prevention of NCDs Through Screening and Educating Individuals on Health-risk Behaviours in the Community
NCT05790395
General-health-promotion-approach to Promoting Healthier Lives
NCT06077565
Social Determinants in Chronic Disease in British Columbia
NCT02203084
Marketing Workplace Chronic Disease Prevention
NCT00452816
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specifically, the investigators consider two cases: a disease caused by a single controllable risk factor (say X) and a disease caused by two risk factors -- a controllable factor (X) and an uncontrollable factor (Y). In both cases, the removal of X can result in a meaningful reduction in overall disease risk. It is hypothesized that even when the magnitude of overall risk reduction brought by the removal of X is the same in the two cases, people would have a lower motivation to remove X in the latter case.
The investigators also examine how the presence of an uncontrollable risk factor interacts with the respondents' regret anticipation to influence their decision to remove X. In the context of the current research, regret anticipation could take one of the following forms: (a) feel regretful if one decides not to remove X and later develops the disease (b) feel regretful if one decides to remove X but still develops the disease. The investigators expect (a) to moderate the effect of uncontrollable risk factor on motivation to remove X.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
There is also a within-subject variable. Each subject will respond to 10 rounds of decision task with 5 different levels of overall disease risk reduction brought by the removal of X. The 5 levels of risk reduction are: (i) Removal of X reduces disease risk from 60% to 50% ; (ii) 60% to 40%; (iii) 60% to 30%; (iv) 60% to 20%; (v) 60% to 10%.
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Uncontrollable factor ABSENT; NO anticipated regret induced
The experiment comprises 10 rounds of decision tasks. For each round, the participant begins with having 130 points, each worth $0.5 (Hong Kong dollars). Different numbers of points are deducted depending on the outcome in each round. After the 10 rounds, the computer randomly selects 1 of the rounds and the points from this round is paid in cash.
There is a chance for the participant to develop a disease. Without prevention, the chance of getting the disease is 60%. A cause, X, is identified for the disease. The participant has to decide whether or not to remove X. Removal of X reduces disease chance; the reduced chance varies between 10% and 50% across the 10 rounds and the exact level is communicated at the beginning of each round. The removal of X costs 30 points. Whether s/he ends up developing the disease or not is determined by a computerized lottery based on these chances. If s/he develops the disease, s/he will lose 100 points.
No interventions assigned to this group
Uncontrollable factor ABSENT; anticipated regret induced
Same description as in the "uncontrollable factor absent, no anticipated regret induced" arm, except that the participants are induced to think to what extent they will feel regretful: a) if s/he decides not to remove X but ends up developing the disease and b) if s/he decides to remove X but still gets the disease.
induction of anticipated regret
higher level of elaboration on potential regret
Uncontrollable factor PRESENT; NO anticipated regret induced
The experiment comprises 10 rounds of decision tasks. For each round, the participant begins with having 130 points, each worth $0.5. Different numbers of points are deducted depending on the outcome in each round. After the 10 rounds, the computer randomly selects 1 of the rounds and the points from this round is paid in cash.
There is a chance for the participant to develop a disease. Without prevention, the chance of getting the disease is 60%. Two causes, X and Y, are identified for the disease. The participant has to decide whether or not to remove X. Removal of X reduces disease chance; the reduced chance varies between 10% and 50% across the 10 rounds and the exact level is communicated at the beginning of each round. The removal of X costs 30 points. Whether s/he ends up developing the disease or not is determined by a computerized lottery based on these chances. If s/he develops the disease, s/he will lose 100 points.
presence of uncontrollable risk factor
the presence of an uncontrollable / unremovable risk factor for a disease
Uncontrollable factor PRESENT; anticipated regret induced
Same as the "uncontrollable factor present, no anticipated regret induced" arm, except that the participants are induced to think to what extent they will feel regretful: a) if s/he decides not to remove X but ends up developing the disease and b) if s/he decides to remove X but still gets the disease.
presence of uncontrollable risk factor
the presence of an uncontrollable / unremovable risk factor for a disease
induction of anticipated regret
higher level of elaboration on potential regret
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
presence of uncontrollable risk factor
the presence of an uncontrollable / unremovable risk factor for a disease
induction of anticipated regret
higher level of elaboration on potential regret
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Toronto
OTHER
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yeung Wing Man
Associate Professor of Marketing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wing Man Yeung, PhD
Role: PRINCIPAL_INVESTIGATOR
Chinese University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chinese University of Hong Kong
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Wing Man Yeung, PhD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Binder S, Nuscheler R. Risk-taking in vaccination, surgery, and gambling environments: Evidence from a framed laboratory experiment. Health Econ. 2017 Dec;26 Suppl 3:76-96. doi: 10.1002/hec.3620.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14507018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.